Exploring epistatic relationships of NO biosynthesis pathway genes in susceptibility to CHD
暂无分享,去创建一个
Congxin Huang | H. Ding | Yu-jun Xu | Daowen Wang | Lan Zhang | Yuan-chao Tu | Yuan-chao Tu | Hu Ding | Xiao-jing Wang | Yu-jun Xu | Lan Zhang | Cong-xin Huang | Dao-wen Wang | Xiao-jing Wang
[1] A. Takeshita,et al. Different Vasculoprotective Roles of NO Synthase Isoforms in Vascular Lesion Formation in Mice , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[2] D. Saur,et al. Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[3] H Yasue,et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. , 1998, Journal of the American College of Cardiology.
[4] Todd Holden,et al. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. , 2006, Journal of theoretical biology.
[5] D. Wilcken,et al. The Glu-298→Asp (894G→T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease , 1999, Journal of Molecular Medicine.
[6] J. Berliner,et al. The role of oxidized lipoproteins in atherogenesis. , 1996, Free radical biology & medicine.
[7] A. Hingorani,et al. A common variant of the endothelial nitric oxide synthase (Glu298-->Asp) is a major risk factor for coronary artery disease in the UK. , 1999, Circulation.
[8] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[9] F. Pociot,et al. Linkage of the human inducible nitric oxide synthase gene to type 1 diabetes. , 2001, The Journal of clinical endocrinology and metabolism.
[10] D. Harrison,et al. Cellular and molecular mechanisms of endothelial cell dysfunction. , 1997, The Journal of clinical investigation.
[11] Xavier Estivill,et al. SNPassoc: an R package to perform whole genome association studies , 2007, Bioinform..
[12] K. Kanazawa,et al. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. , 1998, Circulation.
[13] K. Nakao,et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. , 1996, Circulation.
[14] C. Mamotte,et al. Lack of Evidence for Association between Endothelial Nitric Oxide Synthase Gene Polymorphisms and Coronary Artery Disease in the Australian Caucasian Population , 2001, Journal of cardiovascular risk.
[15] J. Cerhan,et al. Polymorphisms in oxidative stress genes and risk for non-Hodgkin lymphoma. , 2006, Carcinogenesis.
[16] K. Nakao,et al. T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. , 1999, Circulation.
[17] A. Gotto,et al. A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. , 2000, Circulation research.
[18] Jason H. Moore,et al. The Ubiquitous Nature of Epistasis in Determining Susceptibility to Common Human Diseases , 2003, Human Heredity.
[19] D. Harrison,et al. Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[20] T. Reich,et al. A perspective on epistasis: limits of models displaying no main effect. , 2002, American journal of human genetics.
[21] Wj Gauderman,et al. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies , 2006 .
[22] Herrmann,et al. Polymorphisms of the endothelial nitric oxide synthase gene — no consistent association with myocardial infarction in the ECTIM study , 1999, European journal of clinical investigation.
[23] Douglas W. Smith,et al. Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk. , 2007, The Journal of clinical investigation.
[24] K. Channon,et al. Functional Effect of the C242T Polymorphism in the NAD(P)H Oxidase p22phox Gene on Vascular Superoxide Production in Atherosclerosis , 2000, Circulation.
[25] L. Hsu,et al. Lack of association between the Glu298Asp variant of the endothelial nitric oxide synthase gene and the risk of coronary artery disease among Taiwanese. , 2001, Journal of the Formosan Medical Association = Taiwan yi zhi.
[26] P. López-Jaramillo,et al. The L-arginine: nitric oxide pathway. , 1993, Current opinion in nephrology and hypertension.
[27] D. Schaid,et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.
[28] D P Byar,et al. Estimating the population attributable risk for multiple risk factors using case-control data. , 1985, American journal of epidemiology.
[29] Jun Zhu,et al. A generalized combinatorial approach for detecting gene-by-gene and gene-by-environment interactions with application to nicotine dependence. , 2007, American journal of human genetics.
[30] A. Quyyumi,et al. Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function. , 1999, American journal of medical genetics.
[31] M. Kuzuya,et al. Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits. , 1997, Atherosclerosis.
[32] V. Álvarez,et al. Association between the NOS3 (-786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. , 2001, Nitric oxide : biology and chemistry.
[33] W. Sessa. The nitric oxide synthase family of proteins. , 1994, Journal of vascular research.
[34] Yang Wang,et al. Nitric oxide synthases: biochemical and molecular regulation. , 1995, Current opinion in nephrology and hypertension.